IMVT insider buying – Immunovant, Inc.
13 insider purchases since 2016 worth $775.6M by 7 different insiders. Last 12 months: 1 purchases, $350.0M. Most recent filing: 2025-12-12.
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 3 older purchases (before the 5-year window) are listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. Director | $774.9M 6× · 36,869,142 sh | 2020-04-16 2025-12-12 | – | 113,317,007 shares as of 2025-12-12 | Holds - never sold |
| Butchko Julia G. Officer | $190,850 1× · 5,000 sh | 2020-09-11 2020-09-11 | 8× · $2.1M last 2024-08-21 | 441,079 shares as of 2024-08-23 | Sold part |
| Hughes Douglas J. Director | $150,355 1× · 18,247 sh | 2021-08-27 2021-08-27 | 2× · $503,495 last 2025-12-01 | 134,653 shares as of 2026-04-09 | Sold part |
| Pande Atul Director | $123,900 2× · 20,000 sh | 2021-08-13 2022-09-30 | 7× · $1.1M last 2026-08-28 | 138,231 shares as of 2026-08-28 | Sold part |
| Torti Frank Director | $116,200 1× · 20,000 sh | 2022-09-29 2022-09-29 | – | 1,009,228 shares as of 2026-04-09 | Holds - never sold |
| MIGAUSKY GEORGE V Director | $53,550 1× · 7,000 sh | 2021-08-20 2021-08-20 | 1× · $504,567 last 2023-12-01 | 137,251 shares as of 2025-04-03 | Sold part |
| Fromkin Andrew J. Director | $43,450 1× · 5,500 sh | 2021-08-10 2021-08-10 | 4× · $8.6M last 2026-05-28 | 131,400 shares as of 2026-05-29 | Sold part |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 0 | – | – | 29 | $14.4M |
| 2025 | 2 | $686.9M | 1 | 20 | $3.5M |
| 2024 | 0 | – | – | 53 | $9.5M |
| 2023 | 1 | $58.0M | 1 | 27 | $11.8M |
| 2022 | 3 | $2.7M | 3 | 6 | $2.0M |
| 2021 | 4 | $287,255 | 4 | – | – |
| 2020 | 3 | $27.7M | 2 | – | – |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2025-12-12 | Roivant Sciences Ltd. | Director | 16,666,666 | $21.00 | $350.0M | +17.2% | SEC |
| 2025-01-15 | Roivant Sciences Ltd. | Director | 16,845,010 | $20.00 | $336.9M | +21.1% | SEC |
| 2023-10-04 | Roivant Sciences Ltd. | Director | 1,526,316 | $38.00 | $58.0M | +1.9% | SEC |
| 2022-10-07 | Roivant Sciences Ltd. | 10% Owner | 416,667 | $6.00 | $2.5M | +0.6% | SEC |
| 2022-10-04 | Pande Atul | Director | 15,000 | $5.60 | $84,000 | +300.0% | SEC |
| 2022-09-29 | Torti Frank | Director | 20,000 | $5.81 | $116,200 | +5.4% | SEC |
| 2021-08-30 | Hughes Douglas J. | Director | 18,247 | $8.24 | $150,355 | +45.4% | SEC |
| 2021-08-20 | MIGAUSKY GEORGE V | Director | 7,000 | $7.65 | $53,550 | +11.6% | SEC |
| 2021-08-16 | Pande Atul | Director | 5,000 | $7.98 | $39,900 | +12.4% | SEC |
| 2021-08-11 | Fromkin Andrew J. | Director | 5,500 | $7.90 | $43,450 | +13.7% | SEC |
| 2020-09-15 | Butchko Julia G. | Officer | 5,000 | $38.17 | $190,850 | SEC | |
| 2020-09-04 | Roivant Sciences Ltd. | 10% Owner | 380,000 | $33.00 | $12.5M | +0.8% | SEC |
| 2020-04-17 | Roivant Sciences Ltd. | 10% Owner | 1,034,483 | $14.50 | $15.0M | +2.8% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Van Tuyl Christopher | Officer | 2,846 | $36.36 | $103,481 | Sale | SEC |
| 2026-08-28 | Pande Atul | Director | 1,500 | $43.27 | $64,905 | Pre-planned (10b5-1) | SEC |
| 2026-08-21 | Gloria Melanie | Officer | 3,056 | $44.16 | $134,953 | Sale | SEC |
| 2026-07-24 | Pande Atul | Director | 1,500 | $39.80 | $59,700 | Pre-planned (10b5-1) | SEC |
| 2026-07-24 | Stout Jay S | Officer | 2,857 | $38.69 | $110,537 | Sale | SEC |
| 2026-07-24 | Girao Tiago | CFO | 6,798 | $38.69 | $263,015 | Sale | SEC |
| 2026-07-10 | Stout Jay S | Officer | 3,487 | $39.55 | $137,925 | Sale | SEC |
| 2026-07-10 | Gloria Melanie | Officer | 2,036 | $39.55 | $80,532 | Sale | SEC |
| 2026-07-06 | Venker Eric | CEO | 3,092 | $38.48 | $118,980 | Sale | SEC |
| 2026-06-26 | Van Tuyl Christopher | Officer | 17,824 | $38.31 | $682,887 | Sale | SEC |
| 2026-06-26 | Stout Jay S | Officer | 40,000 | $38.31 | $1.5M | Sale | SEC |
| 2026-06-26 | Pande Atul | Director | 1,500 | $38.01 | $57,015 | Pre-planned (10b5-1) | SEC |
| 2026-06-26 | Gloria Melanie | Officer | 17,714 | $38.31 | $678,604 | Sale | SEC |
| 2026-06-26 | Girao Tiago | CFO | 10,000 | $38.46 | $384,600 | Sale | SEC |
| 2026-06-22 | Van Tuyl Christopher | Officer | 2,634 | $35.39 | $93,217 | Sale | SEC |
Showing the latest 15 of 135 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free